Evaluation of Nephroprotective Activity of Cod Liver Oil In Drug Induced Nephrotoxicity
Keywords:
Cod liver oil, Cisplastin, NephrotoxicityAbstract
Cisplatin (a platinum-compound) is a anti-neoplastic drug used in the treatment of various cancers but eventually results in severe adverse effects namely nephrotoxicity or renal disorder through generation of reactive oxygen species (ROS). The existing drugs can cure most of the diseases. Still there is a never ending search for finding new drugs in the hope that it would yield drugs with lesser side effects and better therapeutic benefit than the existing drugs. This work was researched for evaluation of the Nephroprotective activity of Cod liver oil against cisplatin induced nephrotoxicity. The cod liver oil administered orally (0.5, 1, 2 gm/kg/day) for 14 day, cisplatin was administered at the dose of 7 mg/kg for 1st day intraperitoneally. Cisplatin treated group showed increased level of Serum & Urine creatinine, uric acid, urea, which were significantly retrieved in group pre-treated with cod liver oil. In conclusion the histopathological & biochemical parameter confirmed that the cod liver oil protect against cisplatin induced renal damage, probably through its antioxidant activity.
Downloads
References
Ferguson, M. A., Vaidya, V. S. and Bonventre , J. V. (2008) Biomarkers of nephrotoxic acute kidney jnjury. Toxicology 245, 182-193.
Finn, W. and Porter, G. (2003) Urinary biomarkers and nephrotoxicity. Clinical Nephrotoxins (2nd ed), pp. 621-655.
Galley, H. F. (2000) Can acute renal failure be prevented? J. R. Coll. Surg. Edinb. 45, 44-50.
Kohli, H. S., et al. (2000) Treatment-related acute renal failure in the elderly: a hospital -based prospective study. Nephrol. Dial. Transplant. 15, 212-217.
Kirtane, A. J et al, . (2005) Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute cirinary syndromes and normal to mildly reduced glomerular filtration rates. J. Am. Coll. Cardiol. 45, 1781-1786.
Zager, R. A. (1997). Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin. Nephrol. 17, 3-14.
Schnellmann, R. G. and Kelly, K. J. (1999). Pathophysioligy of nephrotoxic acute renal failure, in atlas of diseases of the kidney vol 1. (R. W. Schrier, Ed.), pp 15, 1-15.14.
Schetz, M., Dasta, J., Goldstein, S. and Golper, T. (2005) Drug-induced acute kidney injury. Curr. Opin. Crit. Care 11, 555-565.
Azhar, M.U., et al. (2003) Nephroprotective effect of kulthi (Dolichos biflorus) in gentamicin treated rats, Journal of Science and Pharmacy, 5(2), 50-53.
Sreedevi, Y., Latha, J. P., Bharathi, K., (2011) Protective effect of fruits of Pedalium murex against gentamicin induced nephrotoxicity in rats. International Journal of induced nephrotoxicity in rats. International Journal of Phytopharmacology, 2(1), 27-36.
Hare, R. S. (1950) Endogenous creatinine in serum and urine, Proc. Soc. Exp. Biol. Med, 74, 148.
Borrmann, H. Romeis, B. Mikroskopicheskaia technique. Moscow, 1954 “Mikrotome in Wissenschaft und Forschung.” In Medizintechnik. Berlin. 1958, 102-112.
Beauchamp D, Gourde P, Bergeron, MG. Sub-cellular distribution of gentamycin in proximal tubular cells, determined by immune gold labeling. Antimicrobial Agents and Chemotherapy.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
